Table 2 Correlation between MYBL2 expression and clinicopathological features in 79 glioma patients
From: Akt/FoxM1 signaling pathway-mediated upregulation of MYBL2 promotes progression of human glioma
Clinical characteristic | NO. of patients | NO. of patients | P Valaue | |
|---|---|---|---|---|
High expression(n=24) | Low expression(n=55) | |||
Age (year) | ||||
 ≧45 | 30 | 9 | 21 | 0.474524 |
 <45 | 49 | 15 | 34 | |
Sex | ||||
 Male | 50 | 15 | 35 | 0.329518 |
 female | 29 | 9 | 20 | |
Clinical Stage | ||||
 Low grades I-II | 35 | 4 | 31 | <0.001 |
 High gradesIII - IV | 44 | 20 | 24 | |
Tumor location | ||||
 Frontal | 34 | 10 | 24 | 0.738 |
 Parietal | 13 | 5 | 8 | |
 Occipital | 1 | 1 | 0 | |
 Temporal | 18 | 4 | 14 | |
 Others | 13 | 4 | 9 | |